Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00888602 · ClinicalTrials.gov registry record · NA
Study to Evaluate the Effects of Psyllium on Blood Glucose
A NA study, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT00888602 is a NA study that has completed, run by Procter and Gamble. The registered enrollment target is 49 participants.
The verdict
NCT00888602, a NA study, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
This is an open label, single use, randomized, 4-period cross-over study. In each period, subjects will receive one of 4 test combinations. Blood will be drawn prior to study product consumption and following study product consumption for glucose measures.
Interventions
- OTHER Meal
- DIETARY_SUPPLEMENT 3.4 g psyllium
- DIETARY_SUPPLEMENT 6.8 g psyllium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2009-04 |
| Est. Completion | 2009-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00888602
The ClinicalTrials.gov registry entry for NCT00888602 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Meal is the first listed.
NCT00888602 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00888602 about?
NCT00888602 is a clinical study titled "Study to Evaluate the Effects of Psyllium on Blood Glucose". This is an open label, single use, randomized, 4-period cross-over study. In each period, subjects will receive one of 4 test combinations. Blood will be drawn prior to study product consumption and following study product consumption for glucose measures.
What is the current status of trial NCT00888602?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2009-04. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00888602?
The interventions under investigation include: Meal (OTHER), 3.4 g psyllium (DIETARY_SUPPLEMENT), 6.8 g psyllium (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00888602?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.